Nursing care
Albuterol: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Albuterol is a short-acting beta-2 agonist used for rescue relief of bronchospasm, not for daily control. It works within minutes by relaxing bronchial smooth muscle. Needing it more than twice a week signals poor asthma control and warrants a step-up in therapy. Expect dose-related tremor and tachycardia, and check apical pulse before and after administration.
Mechanism, simply
Albuterol binds beta-2 adrenergic receptors on bronchial smooth muscle, triggering relaxation and bronchodilation within five to fifteen minutes. It is a short-acting beta-2 agonist (SABA), so the effect peaks fast and fades over four to six hours. That short window is precisely why it belongs in the rescue category, not the maintenance category.
At higher doses selectivity for beta-2 receptors weakens, and some drug spills onto beta-1 receptors in the heart. That spillover explains the tachycardia and palpitations patients report after repeated puffs. The tremor comes from beta-2 stimulation in skeletal muscle itself, not from a cardiac effect, so it does not indicate a cardiac problem on its own.
Indications you will see on the ward
You will give albuterol for acute bronchospasm in asthma and COPD exacerbations, as pre-treatment before exercise in exercise-induced bronchospasm, and as a nebulized bridge during a respiratory crisis in the emergency department. It is also used before chest physiotherapy to open airways ahead of suctioning or percussion.
The pattern to recognize on the exam and on the floor: albuterol treats symptoms as they happen. It does not reduce airway inflammation and does not prevent attacks. A patient using it more than twice a week, or waking at night needing it, has inadequately controlled asthma and needs review of their inhaled corticosteroid or controller regimen, not more albuterol.
Assessment before administration
Check baseline heart rate and rhythm before giving albuterol, particularly by nebulizer or in a patient with known cardiac disease, because tachycardia and occasionally dysrhythmias can follow. Auscultate breath sounds before and after the dose to confirm the drug actually reached the airways and improved air movement, not just reduced wheeze intensity.
Ask how many times the patient has used their inhaler in the past 24 hours and in the past week. Frequent use is the single most useful assessment finding here, since it flags deteriorating control before oxygen saturation or peak flow necessarily drops. Review potassium if the patient is on other agents that lower it, since beta-2 agonists can shift potassium intracellularly and worsen hypokalemia.
Toxicity and the antidote
Overuse or overdose produces exaggerated beta effects: marked tachycardia, tremor, anxiety, hypokalemia, and in severe cases dysrhythmias or angina in susceptible patients. There is no specific antidote. Management is supportive: stop the drug, correct hypokalemia, and use a cardioselective beta-blocker cautiously only if a dysrhythmia demands it, since beta-blockade can also worsen bronchospasm.
In practice, toxicity on the ward looks less like a poisoning and more like an anxious, tachycardic patient who has been chain-using their rescue inhaler. Recognizing that pattern and escalating to the provider matters more for the exam and for real practice than memorizing a reversal agent that does not exist.
Interactions that matter
Other beta-agonists, including decongestants like pseudoephedrine, compound the cardiac stimulant effect and increase tremor and tachycardia. Non-selective beta-blockers such as propranolol directly oppose albuterol's action and can precipitate bronchospasm, so they are used with caution or avoided in patients with reactive airway disease.
Loop and thiazide diuretics both lower potassium, and albuterol adds to that effect through intracellular shift, so a patient on furosemide who is also using frequent albuterol needs potassium monitoring. MAO inhibitors and tricyclic antidepressants can potentiate cardiovascular effects and are used cautiously alongside it.
What the patient must be told
Tell the patient this inhaler is for sudden symptoms, not a daily preventer, and to keep it with them at all times for that reason. If they need it more than twice a week outside of pre-exercise use, that is a signal to call their provider about their controller therapy, not a reason to increase how often they reach for the rescue inhaler.
Explain that shakiness and a racing heart after use are expected, dose-related effects that usually settle within an hour, but chest pain, fainting, or a heart rate that will not come down needs urgent attention. Review inhaler technique and spacer use at every visit, since poor technique is the most common reason a patient feels they need extra puffs.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Is albuterol a rescue or a maintenance inhaler?
It is a rescue inhaler only. It relieves acute bronchospasm within minutes but does nothing to reduce the underlying airway inflammation, so it cannot substitute for a daily controller like an inhaled corticosteroid.
Why does albuterol cause tremor and a fast heart rate?
Both are dose-related beta-2 effects. Tremor comes from beta-2 receptors in skeletal muscle, and tachycardia from some loss of receptor selectivity at higher doses spilling onto cardiac beta-1 receptors. They usually resolve without treatment as the drug wears off.
What does it mean if a patient uses albuterol more than twice a week?
It signals inadequate asthma control per standard stepwise management. It is a cue to reassess the controller regimen, not a cue to increase rescue inhaler use, and should be reported to the prescriber.
What should the nurse monitor when giving nebulized albuterol?
Monitor heart rate and rhythm before and after the dose, breath sounds for improved air movement, and potassium if the patient is on other potassium-lowering drugs. Report sustained tachycardia or chest pain.
More on pharmacology
Guides on this